Next year’s rollout of Epi+, a multilingual event-based surveillance platform designed to help countries detect and assess ...

This social media card explains that approx. 60% of infant hospitalisations from RSV could be prevented through immunising 90% of newborns.

Consultation rates for respiratory illness in both primary and secondary care are slowly increasing, but remain at low or baseline levels in all reporting EU/EEA countries. SARS-CoV-2 remains the main ...

This report was produced by the European Centre for Disease Prevention and Control on behalf of the European Respiratory ...

Since the beginning of 2026 and as of 23 March 2026, over 500 000 cases of dengue and over 100 dengue-related deaths had been reported globally according to information from publicly available sources ...

In this video, representatives from ECDC, the European Commission's Directorate-General for Health and Food Safety (DG SANTE), the European Health and Digital Executive Agency (HaDEA) and the World ...

Strong laboratory capacity is the backbone of Europe’s preparedness in the face of increasing communicable disease threats, ...

The first cycle of Public Health Emergency Preparedness Assessments (PHEPAs) coordinated by the European Centre for Disease ...

In this video, representatives of the EURLs explain how they work together to strengthen laboratory capacity across Europe through quality assessments, specialist training, shared testing methods and ...

Watch the presentation of the EU Reference Laboratories for Public Health recorded at ESCAIDE 2025 in Warsaw.

Summary In week 16, 2026, the number of people reporting symptoms of respiratory illness is at baseline to low levels and continues to decrease across the EU/EEA. Respiratory syncytial virus (RSV) ...

Since the start of 2026, and as of 30 September (data collection period 29–30 October, data available up to 30 September), 271 223 chikungunya virus disease (CHIKVD) cases and 113 associated deaths ...